XML 40 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible preferred stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at Beginning at Dec. 31, 2019 $ 3,161 $ 7,935 $ 28 $ 12,883 $ (17,685)  
Balance at Beginning (in Shares) at Dec. 31, 2019   6,687,475 37,031,840      
Common stock issued upon exercise of stock options 364     364    
Common stock issued upon exercise of stock options, shares     335,025      
Share-based compensation expense 919     919    
Net loss (3,668)       (3,668)  
Balance at Ending at Dec. 31, 2020 776 $ 7,935 $ 28 14,166 (21,353) $ 0
Balance at Ending (in Shares) at Dec. 31, 2020   6,687,475 37,366,865      
Common stock issued upon exercise of stock options 1,830   $ 2 1,828    
Common stock issued upon exercise of stock options, shares     2,368,705      
Issuance of restricted stock awards, shares     24,895      
Share-based compensation expense 3,409     3,409    
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount of $10.6 million 107,610   $ 7 107,603    
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount of $10.6 million, shares     6,953,125      
Issuance of common stock upon net exercise of warrants     $ 1 (1)    
Issuance of common stock upon net exercise of warrants, shares     621,570      
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock   $ (7,935) $ 7 7,928    
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock, shares   (6,687,475) 6,845,922      
Net loss (20,552)       (20,552)  
Balance at Ending at Dec. 31, 2021 93,073 $ 0 $ 45 134,933 (41,905) 0
Balance at Ending (in Shares) at Dec. 31, 2021   0 54,181,082      
Common stock issued upon exercise of stock options $ 2,187   $ 10 2,177    
Common stock issued upon exercise of stock options, shares 1,444,626   1,444,626      
Common stock issued for vesting of stock units     2,500      
Share-based compensation expense $ 8,111     8,111    
Net loss (42,815)       (42,815)  
Unrealized loss on available-for-sale marketable securities (27)         (27)
Balance at Ending at Dec. 31, 2022 $ 60,529 $ 0 $ 55 $ 145,221 $ (84,720) $ (27)
Balance at Ending (in Shares) at Dec. 31, 2022   0 55,628,208